Merck (NYSE:MRK) received FDA approval for KEYTRUDA and its new subcutaneous formulation, KEYTRUDA QLEX, in combination ...
EXZOLT™ CATTLE-CA1 is the first in its class and the only product conditionally approved for both the prevention and treatment of New World screwworm and treatment and control of cattle fever tick ...
Merck & Co., Inc. (NYSE:MRK) is one of the best medical research stocks to buy according to hedge funds. Merck & Co., Inc.
Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., ...
Merck's animal care division has received conditional approval from the Food and Drug Administration for a cattle antiparasitic. The company said Thursday the treatment, known as Exzolt Cattle-CA1, ...
In recent weeks, Merck secured new regulatory milestones for its KEYTRUDA franchise, including U.S. FDA approval for KEYTRUDA ...
Merck (MRK) announced that the U.S. FDA has approved an update to the U.S. product label based on the Phase 3 ZENITH trial for WINREVAIR for injection, 45mg, 60mg. WINREVAIR, an activin signaling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results